Agios Pharmaceuticals Celebrates PYRUKYND® Launch Success with Almac Group
Almac Group, the global contract development and manufacturing organisation, hosted a visit from strategic partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in the field of cellular metabolism pioneering therapies for genetically defined diseases, to jointly celebrate the launch of its product PYRUKYND® ...
Source: pharmiweb.com